Copyright Reports & Markets. All rights reserved.

Global 7-Aminocephalosporanic Acid (7-ACA) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Enzymatic Hydrolysis
    • 1.3.3 Chemical Cracking
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Ceftriaxone
    • 1.4.3 Cefazolin
    • 1.4.4 Ceftazidime
    • 1.4.5 Cefotaxime
  • 1.5 Global 7-Aminocephalosporanic Acid (7-ACA) Market Size & Forecast
    • 1.5.1 Global 7-Aminocephalosporanic Acid (7-ACA) Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity (2019-2030)
    • 1.5.3 Global 7-Aminocephalosporanic Acid (7-ACA) Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Yili Chuangning Biotechnology
    • 2.1.1 Yili Chuangning Biotechnology Details
    • 2.1.2 Yili Chuangning Biotechnology Major Business
    • 2.1.3 Yili Chuangning Biotechnology 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.1.4 Yili Chuangning Biotechnology 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Yili Chuangning Biotechnology Recent Developments/Updates
  • 2.2 Joincare Pharmaceutical Group Industry Co.,Ltd.
    • 2.2.1 Joincare Pharmaceutical Group Industry Co.,Ltd. Details
    • 2.2.2 Joincare Pharmaceutical Group Industry Co.,Ltd. Major Business
    • 2.2.3 Joincare Pharmaceutical Group Industry Co.,Ltd. 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.2.4 Joincare Pharmaceutical Group Industry Co.,Ltd. 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Joincare Pharmaceutical Group Industry Co.,Ltd. Recent Developments/Updates
  • 2.3 CSPC Pharmaceutical Group Limited
    • 2.3.1 CSPC Pharmaceutical Group Limited Details
    • 2.3.2 CSPC Pharmaceutical Group Limited Major Business
    • 2.3.3 CSPC Pharmaceutical Group Limited 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.3.4 CSPC Pharmaceutical Group Limited 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
  • 2.4 Sinopharm Weiqida Pharmaceutical Co.,Led.
    • 2.4.1 Sinopharm Weiqida Pharmaceutical Co.,Led. Details
    • 2.4.2 Sinopharm Weiqida Pharmaceutical Co.,Led. Major Business
    • 2.4.3 Sinopharm Weiqida Pharmaceutical Co.,Led. 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.4.4 Sinopharm Weiqida Pharmaceutical Co.,Led. 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Sinopharm Weiqida Pharmaceutical Co.,Led. Recent Developments/Updates
  • 2.5 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd.
    • 2.5.1 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. Details
    • 2.5.2 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. Major Business
    • 2.5.3 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.5.4 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.6 CordenPharma
    • 2.6.1 CordenPharma Details
    • 2.6.2 CordenPharma Major Business
    • 2.6.3 CordenPharma 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.6.4 CordenPharma 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 CordenPharma Recent Developments/Updates
  • 2.7 Dragon Pharma
    • 2.7.1 Dragon Pharma Details
    • 2.7.2 Dragon Pharma Major Business
    • 2.7.3 Dragon Pharma 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.7.4 Dragon Pharma 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Dragon Pharma Recent Developments/Updates
  • 2.8 Nectar Lifesciences
    • 2.8.1 Nectar Lifesciences Details
    • 2.8.2 Nectar Lifesciences Major Business
    • 2.8.3 Nectar Lifesciences 7-Aminocephalosporanic Acid (7-ACA) Product and Services
    • 2.8.4 Nectar Lifesciences 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Nectar Lifesciences Recent Developments/Updates

3 Competitive Environment: 7-Aminocephalosporanic Acid (7-ACA) by Manufacturer

  • 3.1 Global 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global 7-Aminocephalosporanic Acid (7-ACA) Revenue by Manufacturer (2019-2024)
  • 3.3 Global 7-Aminocephalosporanic Acid (7-ACA) Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of 7-Aminocephalosporanic Acid (7-ACA) by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 7-Aminocephalosporanic Acid (7-ACA) Manufacturer Market Share in 2023
    • 3.4.3 Top 6 7-Aminocephalosporanic Acid (7-ACA) Manufacturer Market Share in 2023
  • 3.5 7-Aminocephalosporanic Acid (7-ACA) Market: Overall Company Footprint Analysis
    • 3.5.1 7-Aminocephalosporanic Acid (7-ACA) Market: Region Footprint
    • 3.5.2 7-Aminocephalosporanic Acid (7-ACA) Market: Company Product Type Footprint
    • 3.5.3 7-Aminocephalosporanic Acid (7-ACA) Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global 7-Aminocephalosporanic Acid (7-ACA) Market Size by Region
    • 4.1.1 Global 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Region (2019-2030)
    • 4.1.2 Global 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Region (2019-2030)
    • 4.1.3 Global 7-Aminocephalosporanic Acid (7-ACA) Average Price by Region (2019-2030)
  • 4.2 North America 7-Aminocephalosporanic Acid (7-ACA) Consumption Value (2019-2030)
  • 4.3 Europe 7-Aminocephalosporanic Acid (7-ACA) Consumption Value (2019-2030)
  • 4.4 Asia-Pacific 7-Aminocephalosporanic Acid (7-ACA) Consumption Value (2019-2030)
  • 4.5 South America 7-Aminocephalosporanic Acid (7-ACA) Consumption Value (2019-2030)
  • 4.6 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Type (2019-2030)
  • 5.2 Global 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Type (2019-2030)
  • 5.3 Global 7-Aminocephalosporanic Acid (7-ACA) Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Application (2019-2030)
  • 6.2 Global 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Application (2019-2030)
  • 6.3 Global 7-Aminocephalosporanic Acid (7-ACA) Average Price by Application (2019-2030)

7 North America

  • 7.1 North America 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Type (2019-2030)
  • 7.2 North America 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Application (2019-2030)
  • 7.3 North America 7-Aminocephalosporanic Acid (7-ACA) Market Size by Country
    • 7.3.1 North America 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Country (2019-2030)
    • 7.3.2 North America 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Type (2019-2030)
  • 8.2 Europe 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Application (2019-2030)
  • 8.3 Europe 7-Aminocephalosporanic Acid (7-ACA) Market Size by Country
    • 8.3.1 Europe 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific 7-Aminocephalosporanic Acid (7-ACA) Market Size by Region
    • 9.3.1 Asia-Pacific 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Type (2019-2030)
  • 10.2 South America 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Application (2019-2030)
  • 10.3 South America 7-Aminocephalosporanic Acid (7-ACA) Market Size by Country
    • 10.3.1 South America 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Country (2019-2030)
    • 10.3.2 South America 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Market Size by Country
    • 11.3.1 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa 7-Aminocephalosporanic Acid (7-ACA) Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 7-Aminocephalosporanic Acid (7-ACA) Market Drivers
  • 12.2 7-Aminocephalosporanic Acid (7-ACA) Market Restraints
  • 12.3 7-Aminocephalosporanic Acid (7-ACA) Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of 7-Aminocephalosporanic Acid (7-ACA) and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of 7-Aminocephalosporanic Acid (7-ACA)
  • 13.3 7-Aminocephalosporanic Acid (7-ACA) Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 7-Aminocephalosporanic Acid (7-ACA) Typical Distributors
  • 14.3 7-Aminocephalosporanic Acid (7-ACA) Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global 7-Aminocephalosporanic Acid (7-ACA) market size was valued at US$ 685 million in 2023 and is forecast to a readjusted size of USD 1048 million by 2030 with a CAGR of 6.3% during review period.
    Global key 7-Aminocephalosporanic Acid (7-ACA) players include Joincare Pharmaceutical Group Industry, CSPC Pharmaceutical Group Limited and Sinopharm Weiqida Pharmaceutical etc. The top 3 companies hold a share about 42%. China is the largest market with a share about 63%, followed by North America and Europe.
    In terms of product, enzymatic hydrolysis product is the largest segment with a share about 88%. And in terms of applications, the largest application is Ceftriaxone with a share about 26%.
    This report is a detailed and comprehensive analysis for global 7-Aminocephalosporanic Acid (7-ACA) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global 7-Aminocephalosporanic Acid (7-ACA) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Unit), 2019-2030
    Global 7-Aminocephalosporanic Acid (7-ACA) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Unit), 2019-2030
    Global 7-Aminocephalosporanic Acid (7-ACA) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Unit), 2019-2030
    Global 7-Aminocephalosporanic Acid (7-ACA) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for 7-Aminocephalosporanic Acid (7-ACA)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global 7-Aminocephalosporanic Acid (7-ACA) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Yili Chuangning Biotechnology, Joincare Pharmaceutical Group Industry Co.,Ltd., CSPC Pharmaceutical Group Limited, Sinopharm Weiqida Pharmaceutical Co.,Led., INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd., CordenPharma, Dragon Pharma, Nectar Lifesciences, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    7-Aminocephalosporanic Acid (7-ACA) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Enzymatic Hydrolysis
    Chemical Cracking
    Market segment by Application
    Ceftriaxone
    Cefazolin
    Ceftazidime
    Cefotaxime
    Major players covered
    Yili Chuangning Biotechnology
    Joincare Pharmaceutical Group Industry Co.,Ltd.
    CSPC Pharmaceutical Group Limited
    Sinopharm Weiqida Pharmaceutical Co.,Led.
    INNER MONGOLIA Changsheng Pharmaceutical Co., Ltd.
    CordenPharma
    Dragon Pharma
    Nectar Lifesciences
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe 7-Aminocephalosporanic Acid (7-ACA) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of 7-Aminocephalosporanic Acid (7-ACA), with price, sales quantity, revenue, and global market share of 7-Aminocephalosporanic Acid (7-ACA) from 2019 to 2024.
    Chapter 3, the 7-Aminocephalosporanic Acid (7-ACA) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the 7-Aminocephalosporanic Acid (7-ACA) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and 7-Aminocephalosporanic Acid (7-ACA) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of 7-Aminocephalosporanic Acid (7-ACA).
    Chapter 14 and 15, to describe 7-Aminocephalosporanic Acid (7-ACA) sales channel, distributors, customers, research findings and conclusion.

    Buy now